Literature DB >> 27106479

Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.

Hae Tha Mya1, Hui Ming Tay2, Shien Wen Gan3, Shilpa Surendran2, Shu Hui Yeang4, Cynthia Ciwei Lim3, HuiLin Choong3, Lai Heng Lee2, Heng Joo Ng2.   

Abstract

Increasing awareness and availability of tests for anti-PF4/heparin complex antibodies has raised concerns about indiscriminate testing and inappropriate diagnosis of heparin-induced thrombocytopenia. A retrospective review of HITS testing at a large tertiary centre was performed to determine test patterns and incidence of HITS. Records of anti-PF4 tests over 4 years were reviewed. Positive results were matched against patient medical records and records of heparin utilisation for the diagnosis of HITS. Total of 33,308 patients (9.89 % of admissions) were exposed to at least 1 day of unfractionated heparin (UFH) or low molecular weight heparin (LMWH). Of 346 anti-PF4 antibody assays performed, 52 (15 %) were positive. Seventeen patients (4.9 % of total) were determined to have HITS. Of these, 13 cases (76 %) were patients who were initiated on haemodialysis via central venous catheters. Five patients (29 %) subsequently experienced thrombosis. The rate of HITS in patients given UFH was 0.33 %. HITS occurred in only one patient given LMWH. Of 1337 patients with chronic renal failure initiated on long term haemodialysis, the incidence of HITS was 0.97 %. Despite increased awareness of HITS, testing frequency remains conservative. An overwhelming majority of HITS cases were diagnosed among patients initiated on haemodialysis.

Entities:  

Keywords:  Heparin; Heparin-induced thrombocytopenia; Incidence

Mesh:

Substances:

Year:  2016        PMID: 27106479     DOI: 10.1007/s12185-016-2013-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  30 in total

Review 1.  Heparin-induced thrombocytopenia: a historical perspective.

Authors:  John G Kelton; Theodore E Warkentin
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

2.  Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.

Authors:  T E Warkentin; A Greinacher; Y Gruel; R H Aster; B H Chong
Journal:  J Thromb Haemost       Date:  2011-12       Impact factor: 5.824

3.  Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations.

Authors:  G R Rhodes; R H Dixon; D Silver
Journal:  Surg Gynecol Obstet       Date:  1973-03

4.  Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.

Authors:  Iván Palomo; Jaime Pereira; Marcelo Alarcón; Gonzalo Díaz; Patricia Hidalgo; Isabel Pizarro; Eric Jara; Patricio Rojas; Guillermo Quiroga; Rodrigo Moore-Carrasco
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

5.  Outcome of patients with positive heparin-platelet factor-4 antibodies: A retrospective multi-institutional observational study.

Authors:  Umit Tapan; Saritha Bolla; Ebubekir S Daglilar; Shaoyu Chang; Olga Kozyreva
Journal:  Platelets       Date:  2014-11-10       Impact factor: 3.862

6.  Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia.

Authors:  J Harenberg; G Huhle; C Giese; L C Wang; M Feuring; X H Song; U Hoffmann
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

7.  The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.

Authors:  Marc Carrier; Greg A Knoll; Michael J Kovacs; Jane C Moore; Dean Fergusson; Marc A Rodger
Journal:  Thromb Res       Date:  2006-11-13       Impact factor: 3.944

Review 8.  Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.

Authors:  Douglas B Cines; Lubica Rauova; Gowthami Arepally; Michael P Reilly; Steven E McKenzie; Bruce S Sachais; Mortimer Poncz
Journal:  J Clin Apher       Date:  2007-02       Impact factor: 2.821

9.  Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.

Authors:  A Greinacher; S Alban; M A Omer-Adam; W Weitschies; T E Warkentin
Journal:  Thromb Res       Date:  2008-02-08       Impact factor: 3.944

10.  Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar.

Authors:  Charles Fs Locke; John Dooley; Jonathan Gerber
Journal:  Thromb J       Date:  2005-04-04
View more
  1 in total

1.  Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin.

Authors:  Satish Maharaj; Simone Chang; Karan Seegobin; James Morales; Agnes Aysola; Fauzia Rana; Marwan Shaikh
Journal:  Exp Hematol Oncol       Date:  2018-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.